Genentech Exec Heads East To Take The Reins Of Cancer-Focused Start-up Agios
This article was originally published in The Pink Sheet Daily
Executive Summary
Calling it “the right time and the right opportunity,” Genentech’s cancer drug development expert David Schenkein plans to move on.